Nasalcrom and Atrovent drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nasalcrom (cromolyn sodium) and Atrovent (ipratropium bromide). Common drug interactions include cytomegalovirus infection among females and dyspepsia among males.

The phase IV clinical study analyzes what interactions people have when they take Nasalcrom and Atrovent. It is created by eHealthMe based on reports of 51 people who take the same drugs from the FDA, and is updated regularly.

What is Nasalcrom?

Nasalcrom has active ingredients of cromolyn sodium. It is often used in allergies. eHealthMe is studying from 1,528 Nasalcrom users. Check the latest studies of Nasalcrom.

What is Atrovent?

Atrovent has active ingredients of ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 33,210 Atrovent users. Check the latest studies of Atrovent.

On Jul, 13, 2026

51 people who take Nasalcrom and Atrovent together, and have interactions are studied.

Nasalcrom and Atrovent drug interactions.

What are the common drug interactions of Nasalcrom and Atrovent, by gender? *:

female:

Cytomegalovirus infection
Dizziness
Epstein-barr virus infection
Foot fracture
Laryngitis (inflammation of the larynx)
Nausea (feeling of having an urge to vomit)
Oedema (fluid collection in tissue)
Pain
Pneumonia mycoplasmal (mycoplasma pneumonia (mp) is a contagious respiratory infection)
Drug ineffective

male:

Dyspepsia (indigestion)
Arrhythmia (irregular heartbeat)
Drug dependence
Haemorrhoids (a swollen vein or group of veins in the region of the anus)
Hypersomnia (excessive daytime sleepiness (eds))
Hypothermia (body temperature drops below the required temperature for normal metabolism and body functions)
Nasal turbinate hypertrophy (nasal turbinates become enlarged)
Osteopenia (a condition where bone mineral density is lower than normal)
Parathyroid tumour benign (parathyroid tumour non-cancerous)
Renal disorder (kidney disease)

What are the common drug interactions of Nasalcrom and Atrovent, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Bacterial infection
Contusion (a type of hematoma of tissue in which capillaries)
Cytomegalovirus infection
Epstein-barr virus infection
Hypersensitivity
Infectious mononucleosis (infection usually caused by the epstein-barr virus)
Infusion site haemorrhage (bleeding from infusion site)
Infusion site pain
Laryngitis (inflammation of the larynx)
Pneumonia mycoplasmal (mycoplasma pneumonia (mp) is a contagious respiratory infection)

40-49:

Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
Drug toxicity
Hepatic failure (liver failure)
Hepatitis (inflammation of the liver)
Urticaria (rash of round, red welts on the skin that itch intensely)
Haemorrhage (bleeding)
Syncope (loss of consciousness with an inability to maintain postural tone)
Tinnitus (a ringing in the ears)
Diarrhoea
Headache (pain in head)

50-59:

Migraine (headache)
Myalgia (muscle pain)
Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
Nausea (feeling of having an urge to vomit)
Neck pain
Oedema (fluid collection in tissue)
Oedema peripheral (superficial swelling)
Oesophageal candidiasis (fungal infection of oesophagus)
Oesophageal stenosis (narrowing of oesophagus)
Oral candidiasis (fungal infection of mouth)

60+:

Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Fall
Dyspnoea (difficult or laboured respiration)
Erythema (redness of the skin)
Fatigue (feeling of tiredness)
Head injury
Loss of consciousness
Malaise (a feeling of general discomfort or uneasiness)
Memory impairment
Multiple allergies (allergy to multiple agents)

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 13 people, 25.49%
Asthma: 5 people, 9.80%
Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose): 3 people, 5.88%
Hypersensitivity: 3 people, 5.88%
High Blood Cholesterol: 3 people, 5.88%
Adenoma Benign (non-cancerous tumour -secreting): 3 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Nasalcrom and Atrovent?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously